Huntington's Disease Global Clinical Trials Review, H2, 2013" provides data on the Huntingtons Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Huntingtons Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Huntingtons Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy Understand the dynamics of a particular indication in a condensed manner Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Get Detail Report with TOC At : http://www.researchmoz.us/huntingtons-disease-global-clinical-trials-review-h2-2013-report.html

1. Huntington's Disease Global Clinical Trials Review, H2, 2013
Huntington's Disease Global Clinical Trials Review, H2, 2013
Summary
GlobalData's clinical trial report, Huntington's Disease Global Clinical Trials Review, H2, 2013" provides data
on the Huntingtons Disease clinical trial scenario. This report provides elemental information and data relating
to the clinical trials on Huntingtons Disease. It includes an overview of the trial numbers and their recruitment
status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of
disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing
pertaining to the number of trials for the key drugs for treating Huntingtons Disease. This report is built using
data and information sourced from proprietary databases, primary and secondary research and in-house
analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data
for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe,
Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical
trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type
and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table Of Contents
table Of Contents 2
list Of Tables 5
list Of Figures 6
introduction 7
huntington's Disease 7
report Guidance 7
Huntington's Disease Global Clinical Trials Review, H2, 2013

2. clinical Trials By Region 8
clinical Trials By Country 9
top Five Countries Contributing To Clinical Trials In Asia-pacific 11
top Five Countries Contributing To Clinical Trials In Europe 12
top Countries Contributing To Clinical Trials In North America 13
clinical Trials By Bric Nations 14
clinical Trials By G7 Nations 15
clinical Trials In G7 Nations By Trial Status 16
clinical Trials By E7 Nations 17
clinical Trials In E7 Nations By Trial Status 18
clinical Trials By Phase 19
in Progress Trials By Phase 20
clinical Trials By Trial Status 21
unaccomplished Trials Of Huntington's Disease 22
subjects Recruited Over A Period Of Time 24
prominent Sponsors 25
top Companies Participating In Huntington's Disease Therapeutics Clinical Trials 27
prominent Drug Comparison 29
clinical Trial Profiles 30
clinical Trial Overview Of Top Companies 30
pfizer Inc. 30
clinical Trial Overview Of Pfizer Inc. 30
siena Biotech S.p.a. 31
clinical Trial Overview Of Siena Biotech S.p.a. 31
medivation, Inc. 32
clinical Trial Overview Of Medivation, Inc. 32
omeros Corporation 33
clinical Trial Overview Of Omeros Corporation 33
teva Pharmaceutical Industries Limited 34
clinical Trial Overview Of Teva Pharmaceutical Industries Limited 34
the Avicena Group, Inc. 35
clinical Trial Overview Of The Avicena Group, Inc. 35
neurosearch A/s 36
clinical Trial Overview Of Neurosearch A/s 36
glaxosmithkline Llc 37
clinical Trial Overview Of Glaxosmithkline Llc 37
a. Carlsson Research Ab 38
clinical Trial Overview Of A. Carlsson Research Ab 38
laxdale Limited 39
clinical Trial Overview Of Laxdale Limited 39
prestwick Pharmaceuticals, Inc. 40
clinical Trial Overview Of Prestwick Pharmaceuticals, Inc. 40
auspex Pharmaceuticals, Inc. 41
Huntington's Disease Global Clinical Trials Review, H2, 2013

3. clinical Trial Overview Of Auspex Pharmaceuticals, Inc. 41
amarin Corporation Plc 42
clinical Trial Overview Of Amarin Corporation Plc 42
amarin Neuroscience Ltd. 43
clinical Trial Overview Of Amarin Neuroscience Ltd. 43
raptor Pharmaceuticals Corp. 44
clinical Trial Overview Of Raptor Pharmaceuticals Corp. 44
prana Biotechnology Limited 45
clinical Trial Overview Of Prana Biotechnology Limited 45
sanguine Corporation 46
clinical Trial Overview Of Sanguine Corporation 46
h. Lundbeck A/s 47
clinical Trial Overview Of H. Lundbeck A/s 47
novartis Ag 48
clinical Trial Overview Of Novartis Ag 48
glaxosmithkline Plc 49
clinical Trial Overview Of Glaxosmithkline Plc 49
clinical Trial Overview Of Top Institutes / Government 50
massachusetts General Hospital 50
clinical Trial Overview Of Massachusetts General Hospital 50
cardiff University 51
clinical Trial Overview Of Cardiff University 51
university Of Ulm 52
clinical Trial Overview Of University Of Ulm 52
university Hospital, Angers 53
clinical Trial Overview Of University Hospital, Angers 53
university Of Rochester 54
clinical Trial Overview Of University Of Rochester 54
the University Of Iowa 55
clinical Trial Overview Of The University Of Iowa 55
assistance Publique - Hopitaux De Paris 56
clinical Trial Overview Of Assistance Publique - Hopitaux De Paris 56
institut National De La Sante Et De La Recherche Medicale 57
clinical Trial Overview Of Institut National De La Sante Et De La Recherche Medicale 57
national Institute Of Neurological Disorders And Stroke 58
clinical Trial Overview Of National Institute Of Neurological Disorders And Stroke 58
the Ohio State University 59
clinical Trial Overview Of The Ohio State University 59
institute For Neurodegenerative Disorders 60
clinical Trial Overview Of Institute For Neurodegenerative Disorders 60
chdi Foundation, Inc. 61
clinical Trial Overview Of Chdi Foundation, Inc. 61
national Human Genome Research Institute 62
Huntington's Disease Global Clinical Trials Review, H2, 2013

4. clinical Trial Overview Of National Human Genome Research Institute 62
the Huntington Study Group 63
clinical Trial Overview Of The Huntington Study Group 63
tohoku University School Of Medicine 64
clinical Trial Overview Of Tohoku University School Of Medicine 64
the University Of British Columbia 65
clinical Trial Overview Of The University Of British Columbia 65
seoul National University Hospital 66
clinical Trial Overview Of Seoul National University Hospital 66
the University Of Edinburgh 67
clinical Trial Overview Of The University Of Edinburgh 67
university Of California, Los Angeles 68
clinical Trial Overview Of University Of California, Los Angeles 68
heinrich-heine University 69
clinical Trial Overview Of Heinrich-heine University 69
five Key Clinical Profiles 70
appendix 105
abbreviations 105
definitions 105
research Methodology 106
secondary Research 106
about Globaldata 107
contact Us 107
disclaimer 107
source 107
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research
reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our
huge collection of market research reports. We provide our services to all sizes of organizations and across all
industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as
publishers and will assist you in making an informed decision by giving you unbiased and deep insights on
which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
Huntington's Disease Global Clinical Trials Review, H2, 2013

5. Huntington's Disease Global Clinical Trials Review, H2, 2013